3201 - 3225 of 9033 Results
Title
Year
- Posters2020OPENTitle: PostersJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 7Issue #:Start Page: 55End Page: 119Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.14283/jpad.2020.58Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2020.58.pdfCitation Count: 0
-
OPENTitle: Pathogenic LRRK2 requires secondary factors to induce cellular toxicityJournal Name: Bioscience ReportsPublisher: Portland Press Ltd.Vol: 40Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bsr20202225Best OA location URL: https://portlandpress.com/bioscirep/article-pdf/40/10/BSR20202225/894975/bsr-2020-2225.pdfCitation Count: 3
-
OPENTitle: Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNAJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 3Start Page: 1457End Page: 1467Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1905057117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1457.full.pdfCitation Count: 121
-
OPENTitle: Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activityJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 29Start Page: 17296End Page: 17307Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1922184117Best OA location URL: https://www.pnas.org/content/pnas/117/29/17296.full.pdfCitation Count: 69
-
OPENTitle: µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's DiseaseJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 40Issue #: 35Start Page: 6812End Page: 6819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1523/jneurosci.0610-20.2020Best OA location URL: https://www.jneurosci.org/content/jneuro/40/35/6812.full.pdfCitation Count: 28
-
OPENTitle: Identifying Treatments for Taste and Smell Disorders: Gaps and OpportunitiesJournal Name: Chemical SensesPublisher: Oxford University Press (OUP)Vol: 45Issue #: 7Start Page: 493End Page: 502Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/chemse/bjaa038Best OA location URL: https://academic.oup.com/chemse/article-pdf/45/7/493/33855469/bjaa038.pdfCitation Count: 46
-
OPENTitle: Multimodal Balance Training Supported by Rhythmic Auditory Stimuli in Parkinson Disease: Effects in Freezers and NonfreezersJournal Name: Physical TherapyPublisher: Oxford University Press (OUP)Vol: 100Issue #: 11Start Page: 2023End Page: 2034Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/ptj/pzaa146Best OA location URL: https://academic.oup.com/ptj/article-pdf/100/11/2023/34057810/pzaa146.pdfCitation Count: 28
-
OPENTitle: Frontostriatal Structural Connectivity and Striatal Glutamatergic Levels in Treatment-Resistant Schizophrenia: An Integrative Analysis of DTI and 1H-MRSJournal Name: Schizophrenia Bulletin OpenPublisher: Oxford University Press (OUP)Vol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/schizbullopen/sgaa057Best OA location URL: https://academic.oup.com/schizbullopen/advance-article-pdf/doi/10.1093/schizbullopen/sgaa057/34032787/sgaa057.pdfCitation Count: 7
- Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical Practice2020RESTRICTEDTitle: Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical PracticeJournal Name: Molecular BiologyPublisher: Pleiades Publishing LtdVol: 54Issue #: 6Start Page: 827End Page: 839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1134/s0026893320060060Citation Count: 2
-
OPENTitle: Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific NanobodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 477Issue #: 7Start Page: 1203End Page: 1218Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/bcj20190843Citation Count: 17
-
OPENTitle: Antiglutamic Acid Decarboxylase 65 Antibody–Associated HemiataxiaJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 4Start Page: e564End Page: e566Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000939Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8382435Citation Count: 2
-
OPENTitle: Letter: Evaluation and Surgical Treatment of Functional Neurosurgery Patients With Implanted Deep Brain Stimulation and Vagus Nerve Stimulation Pulse Generators During the COVID-19 PandemicJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 87Issue #: 2Start Page: E222End Page: E226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/neuros/nyaa185Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7239172Citation Count: 8
-
OPENTitle: Brain perfusion patterns are altered in chronic knee pain: a spatial covariance analysis of arterial spin labelling MRIJournal Name: PainPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 161Issue #: 6Start Page: 1255End Page: 1263Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1097/j.pain.0000000000001829Best OA location URL: https://doi.org/10.1097/j.pain.0000000000001829Citation Count: 24
- Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s disease2020OPENTitle: Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s diseaseJournal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 49Issue #: 5Start Page: 786End Page: 792Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/ageing/afaa033Best OA location URL: https://academic.oup.com/ageing/article-pdf/49/5/786/33677028/afaa033.pdfCitation Count: 27
-
OPENTitle: ACValidator: A novel assembly-based approach for in silico verification of circular RNAsJournal Name: Biology Methods and ProtocolsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 1Start Page: bpaa010End Page: bpaa010Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/biomethods/bpaa010Best OA location URL: https://academic.oup.com/biomethods/article-pdf/5/1/bpaa010/33624179/bpaa010.pdfCitation Count: 5
- Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study2019RESTRICTEDTitle: Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 51End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.008Citation Count: 39
-
OPENTitle: Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 73End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.019Best OA location URL: https://arxiv.org/pdf/2201.09654Citation Count: 20
- Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease2020RESTRICTEDTitle: Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s DiseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 433Issue #:Start Page: 53End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.02.046Citation Count: 46
- Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson’s disease2020RESTRICTEDTitle: Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson’s diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 739Issue #:Start Page: 135443End Page: 135443Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2020.135443Citation Count: 11
-
OPENTitle: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S54End Page: S63Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.10.027Citation Count: 42
- Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis2020RESTRICTEDTitle: Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 100End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.026Citation Count: 40
-
OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 23
- Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study2020OPENTitle: Disease progression and prognostic factors in multiple system atrophy: A prospective cohort studyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104813End Page: 104813Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104813Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0969996120300887?via%3DihubCitation Count: 92
-
OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 38
-
OPENTitle: Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 56End Page: 62Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.002Best OA location URL: http://www.prd-journal.com/article/S1353802020300973/pdfCitation Count: 55